Effects of tacrine on deficits in active avoidance performance induced by AF64A in rats

Molecular and Chemical Neuropathology

Volumn 33, Issue 1, 1998, Pages 51-61

  Lermontova, Nadejda ^a   Lukoyanov, Nikolai ^a   Serkova, Tatyana ^a   Lukoyanova, Elena ^a   Bachurin, Sergei ^a  

^a INSTITUTE OF PHYSIOLOGICALLY ACTIVE COMPOUNDS   (Russian Federation)

Author keywords

Active avoidance test; Alzheimer disease; Chemically induced; Neurotoxin AF64A; Rats; Tacrine

Indexed keywords

ETHYLCHOLINE MUSTARD AZIRIDINIUM; NEUROTOXIN; TACRINE;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVOIDANCE BEHAVIOR; BRAIN NECROSIS; CONTROLLED STUDY; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; LEARNING; LONG TERM MEMORY; MALE; NERVE CELL DEGENERATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031917682     PISSN: 10447393     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02815859     Document Type: Article

References (30)

1. Abe E., Murai S., Saito H., Masuda Y., Takasu Y., Shiotani T., Tachizawa H., and Itoh T. (1994) Effects of nefiracetam on deficits in active avoidance response and hippocampal cholinergic and monoaminergic dysfunctions induced by AF64A in mice. J. Neural Transm. Gen. Sect. 95, 179-193.
2. Bailey E. L., Overstreet D. N., and Crocer A. D. (1986) Effects of intrahippocampal injections of the cholinergic neurotoxin AF64A on open-field activity and avoidance learning in the rat. Behav. Neural Biol. 45, 263-284.
3. Bures J., Buresova O., and Huston J. P. (1983) Techniques and Basic Experiments for the Study of Brain and Behavior. Elsevier, Amsterdam.
4. Cacabelos R., Nordberg A., Caamano J., Franco-Maside A., Fernandez-Novoa L., Gomer M. J., Alvarez X. A., Takeda M., Prous J., Nishimura T., and Winblad B. (1994) Molecular strategies for the first generations of antidementia drugs (1). Tacrine and related compounds. Drugs Today 30, 259-337.
5. Chrobak J. J., Spates M. J., Stackman R. W., and Walsh T. J. (1989) Hemicholinium-3 prevents the working memory impairments and the cholinergic hypofunction induced by ethylcholine aziridinium ion (AF64A). Brain Res. 504, 269-275.
6. Fisher A. and Hanin I. (1980) Choline analogs as a potential tools in developing selective animal models of central cholinergic hypofunction. Life Sci. 27, 1615-1634.
7. Fisher A. and Hanin I. (1986) Potential animal models for senile dementia of Alzheimer's type with amphasis on AF64A-induced cholinotoxicity. Annu. Rev. Pharmacol. Toxicol. 26, 161-181.
8. Fisher A., Brandies R., Pittel Z., Karton I., Sapir M., Dachier S., Levy A., and Heldman E. (1989) (±)-cis-2-Methyl-spiro(1,3-oxathiolane-5,3′)quinuclidine (AF102B): a new M1 agonist attenuates cognitive dysfunctions in AF64A-treated rats. Neurosci. Lett. 102, 325-331.
9. Freeman S. E. and Dawson R. M. (1991) Tacrine; a pharmacological review. Prog. Neurobiol. 36, 257-277.
10. Gower A., Rousseau D., Jasmin P., Gobert J., Hanin I., and Wulfert E. (1989) Behavioral and histological effects of low concentrations of intraventricular AF64A. Eur. J. Pharmacol. 166(2), 271-281.
11. Gozes I., Bardea A., Reshef A., Zamostiano R., Zhukovsky, Rubinraut S., Fridkin M., and Brenneman D. (1996) Neuroprotective strategy for Alzheimer disease: Intranasal administration of a fatty neuropeptide. Proc. Natl. Acad. Sci. USA 93, 427-453.
12. Hanin I. (1996) The AF64A model of cholinergic hypofunction: an update. Life Sci. 58, 1955-1964.
13. Hashimoto M., Hashimoto T., and Kuriyama K. (1991) Protective effect of WEB 1881 FU on AF64A-induced impairment of hippocampal cholinergic neurons and learning acquisition. Eur. J. Pharmacol. 209, 9-14.
14. Hodges H., Ribeiro A., Gray J. A., and Marchbanks R. M. (1990) Low dose tetrahydroaminoacridine (THA) improves cognitive function in lesioned and alcohol-treated rats but does not affect brain acetylcholine. Pharmacol. Biochem. Behav., 36, 291-299.
15. Kasa P., Szerdahelyi P., Fisher A., and Hanin I. (1986) Histochemical and electronmicroscopic study of the AF64A-treated rat, in Advances in Behavioral Biology, vol. 29, Alzheimer's and Parkinson's Disease (Fisher A., Hanin I., and Lachman, eds.), Plenum, New York, pp. 447-460.
16. Murai S., Saito H., Abe E., Masuda Y., Odashima J., and Itoh T. (1994) MKC-231, a choline uptake enhancer, ameliorates working memory deficits and decreased hippocampal acetylcholine induced by ethylcholine aziridinium ion in mice. J. Neural. Transm. Gen. Sect. 98, 1-13.
17. Nabeshima T., Maruyama E., Katoh A., and Kameyama T. (1991) The effects of tacrine (THA) on cycloheximide- and basal forebrain lesion-induced memory deficit in rat. Jpn. J. Pharmacol., 57(3), 311-319.
18. Nakahara N., Iga Y., Mizobe F., and Kavanishi G. (1988) Effects of intracerebroventricular injection of AF64A on learning behaviors in rats. Jpn. J. Pharmacol. 48, 121-130.
19. Ogura H., Yamanishi Y., and Yamatsu K. (1987) Effects of physostigmine on AF64A-induced impairment of learning acquisition in rats. Jpn. J. Pharmacol. 44, 498-501.
20. Pellegrino L. J., Pellegrino A. S., and Cushman A. J. (1981) Stereotaxic Atlas of the Rat Brain, 2nd ed., Plenum, New York.
21. Prous, J. R. (ed.) The Year's Drug News (1995) Prous Science, Barcelona, pp. 91-113.
22. Riekkinen P. Jr. and Riekkinen M. (1995) Effects of tetrahydroaminoacridine and nicotine in nucleus basalis and serotonin-lesioned rats. Eur J. Pharmacol. 279, 65-73.
23. Riekkinen P. Jr., Sirvio J., Riekkinen M., and Riekkinen P. (1991) Effects of THA on passive avoidance retention performance of intact, nucleus basalis, frontal cortex and nucleus basalis + frontal cortex-lesioned rats. Pharmacol. Biochem. Behav. 39, 841-846.
24. Riekkinen P. Jr., Riekkinen M., and Sirvio J. (1992) Effects of tetrahydroaminoacridine on spatial navigation of nucleus-basalis- and frontal-cortex-lesioned rats. Pharmacol. Biochem. Behav. 41, 637-641.
25. Sherman K. and Messamore E. (1989) Cholinesterase inhibitor therapy for Alzheimer dementia: what do animal models tell us? Prog. Clin. Biol. Res. 317, 1209-1222.
26. Speiser Z., Reicher S., Gitter S., and Cohen S. (1989) Tacrine or arecoline mediates reversal of anoxia- or AF64A-induced behavioural disorders in the developing rat. Neuropharmacology 12, 1325-1332.
27. Walsh T. and Hanin I. (1986) A review of effects of AF64A, a cholinergic neurotoxin, in Advances in Behavioral Biology, vol. 29, Alzheimer's and Parkinson's Disease (Fisher A., Hanin I., and Lachman, eds.), Plenum, New York, pp. 461-467.
28. Walsh T. and Opello K. (1994) The use of AF64A to model Alzheimer disease, in Toxin-Induced Models of Neurological Disorders (Woodruff M. L. and Nonneman A. J., eds.), New York, Plenum, pp. 259-279.
29. Woodruff M. L. and Baisden R. H. (1994) Trimethyltin neurotoxicity in the rat as an analogous model of Alzheimer's disease, in Toxin-Induced Models of Neurological Disorders (Woodruff M. L. and Nonneman A. J., eds.), Plenum, New York, pp. 319-336.
30. Yokel R. A. (1994) Aluminium exposure produces learning and memory deficits: a model of Alzheimer's disease, in Toxin-Induced Models of Neurological Disorders (Woodruff M. L. and Nonneman A. J., eds.), Plenum, pp. 301-318.